Floatz logo

142 assets in Schizophrenia

Therapeutic assets addressing Schizophrenia, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Rituximab
Schizophrenia
Uppsala University HospitalP2CCC (48)
S1RA
Schizophrenia
China Medical University HospitalP2CCC (48)
spg302
Schizophrenia
SpinogenixP2CCC (48)
mk-4334
Schizophrenia
Merck Sharp & Dohme LLCP1CC (47)
ml-007c-ma
Schizophrenia
MapLight TherapeuticsP2CC (45)
MK8189
Schizophrenia
Merck Sharp & Dohme LLCP1CC (44)
Sep-380135
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc.P1CC (44)
Brexpiprazole Long-Acting
Schizophrenia
Sichuan Kelun Pharmaceutical Co.,Ltd.P1CC (43)
ly03017
Schizophrenia
Luye Pharma Group Ltd.P1CC (43)
Acetazolamide
Schizophrenia
Vishwajit Nimgaonkar, MD PhDP1/2CC (41)
Cromoglycate
Schizophrenia
Vishwajit Nimgaonkar, MD PhDP1/2CC (41)
Midomafetamine
Schizophrenia
Anya Bershad, MD, PhDP1/2CC (41)
Ocrelizumab
Schizophrenia
The Methodist Hospital Research InstituteP1/2CC (41)
mk-5720
Schizophrenia
Merck Sharp & Dohme LLCP1CC (40)
Quinidine Mono-D-Gluconate
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc.P1CC (40)
Vhx-896
Schizophrenia
Vanda PharmaceuticalsP1CC (40)
Zagociguat
Schizophrenia
Tisento TherapeuticsP1CC (40)
18F-AZAN
Schizophrenia
Washington University School of MedicineP1C (37)
ASEM
Schizophrenia
Washington University School of MedicineP1C (37)
Delta-9-Thc
Schizophrenia
Yale UniversityP1C (37)
E. Coli Endotoxin
Schizophrenia
University of Maryland, BaltimoreP1C (37)
hs-10509
Schizophrenia
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (37)
Riluzole
Schizophrenia
King's College LondonEarly P1C (37)
Tpn-672
Schizophrenia
Jiangsu Kanion Pharmaceutical Co., LtdP1C (37)
Ucb-J
Schizophrenia
Davidzon, Guido, M.D.P1C (37)
Urb-597
Schizophrenia
Central Institute of Mental Health, MannheimP1C (37)
vv119
Schizophrenia
Vigonvita Life SciencesP1C (37)
Synthetic Levothyroxine
Schizophrenia
Peking UniversityEarly P1C (34)
Aticaprant
Schizophrenia
Janssen Research & Development, LLCP1D (30)
Monomethyl Fumarate
Schizophrenia
King's College LondonN/AD (30)
Sodium Alginate
Schizophrenia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)N/AD (30)
.Gamma.-Cyclodextrin, 6A,6B,6C,6D,6E,7F,6G,6H-Octakis-S-(2-Carboxyethyl)-6A,6B,6C,6D,6E,7F,6G,6H-Octathio-
Schizophrenia
Medipol UniversityN/AD (28)
Maltodextrin
Schizophrenia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)N/AD (28)
Prucalopride
Schizophrenia
University of PittsburghN/AD (28)
3- qlm1016
Schizophrenia
Qilu Pharmaceutical Co., Ltd.P3NR ()
Ashwagandha
Schizophrenia
Hasanuddin UniversityP2NR ()
ax251 lai
Schizophrenia
Anxo Pharmaceutical Co., Ltd.P1NR ()
Hdfscs-Exo
Schizophrenia
Zigong Mental Health CenterEarly P1NR ()
kr23248
Schizophrenia
Jiangxi Kvvit Pharmaceutical Co., Ltd.P1NR ()
ns-136
Schizophrenia
NeuShen TherapeuticsP2NR ()
Ntx-253
Schizophrenia
NeurosterixEarly P1NR ()
Sipi6398 Tablets
Schizophrenia
Shanghai Zhongze Therapeutics Co., Ltd.P1/2NR ()
Showing 101 to 142 of 142 assets
PreviousPage 3 of 3Next